Ligand VEGFC (a positive regulation signaling of lymph angiogenesis) could interact with receptor FLT4 to upregulate target gene TGFB1, which is a tumor promoter in this carcinogenic progression to induce cancer cell proliferation, migration and EMT. This evidence concerns the gene FLT4 and cancer.